2658-6533Research Results in Biomedicine2658-653310.18413/2313-8955-2015-1-4-56-61497PharmacologyENDOTHELIO-AND CARDIOPROTECTIVE EFFECTS OF HMG-Co-A REDUCTASE IN ENDOTOKSIN-INDUCING ENDOTELIAL DYSFUNCTIONENDOTHELIO-AND CARDIOPROTECTIVE EFFECTS OF HMG-Co-A REDUCTASE IN ENDOTOKSIN-INDUCING ENDOTELIAL DYSFUNCTIONDenisiukTatiana A.DenisiukTatiana A.denitatyana@yandex.ru20151400

The use of inhibitors of HMG-Co-A reductase inhibitor Simvastatin, Atorvastatin, Rosuvastatin and nanoparticulated Rosuvastatin on the background modeling of endotoxin-induced pathology through introduction of strain 603 Staphylococcusaureus leads to the development of dose-response endothelioprotective action which is expressed in the normalization of QED, prevention of increase of adrenoreactivity and exhaustion of myocardial reserve and normalization of biochemical markers of inflammation (C-reactive protein) and the level of proinflammatory cytokines. Besides, the positive dynamics of end-products of NO and expression of eNOS is detected.

The use of inhibitors of HMG-Co-A reductase inhibitor Simvastatin, Atorvastatin, Rosuvastatin and nanoparticulated Rosuvastatin on the background modeling of endotoxin-induced pathology through introduction of strain 603 Staphylococcusaureus leads to the development of dose-response endothelioprotective action which is expressed in the normalization of QED, prevention of increase of adrenoreactivity and exhaustion of myocardial reserve and normalization of biochemical markers of inflammation (C-reactive protein) and the level of proinflammatory cytokines. Besides, the positive dynamics of end-products of NO and expression of eNOS is detected.

endothelial dysfunctionHMG-Co-A-reductase inhibitorendotoxinendothelial dysfunctionHMG-Co-A-reductase inhibitorendotoxinСписок литературы1. Artyushkova E.V., Pokrovskiy M.V., Artyushkova E.B., Korokin M.V. Gudyrev O.S., Belous A.S. Endotelio- and cardioprotective effects meldonium trimetazidine and at l-name-induced endothelial dysfunction in experiment // Kursk scientific-practical herald «Man and his health». 2010. № 3. Р. 5-10.2. Gumanova N.G., Arshjushkova E.B., Meshel'skaja V.A., Kochkarov V.I., Pokrovskaja T.G., Danilenko L.M., Korneev M.M., Pokrovskiy M.V., Pashin E.N. Effect of resveratrol on antioksidantovq510 and regulatory endothelial function in rats with simulated arterial hypertension // Bulletin of Experimental Biology and Medicine. 2007. T. 143. № 6. Р. 619-622.3. Knyazeva S.G., Lazarev A.I., Rybnikov V.N., Konoplya A.A., Gracheva G.V., Lomakina O.P., Gavrilyuk V.P., Kelekhsaeva L.E. Clinical and immunological efficacy imunofana, glutoksima mexidol and in patients with chronic salpingo in the conditions of use of laparoscopic treatment // Kursk scientific-practical herald «Man and his health». 2007. № 3. Р. 74-81.4. Korokin M.V., Pokrovskiy M.V., Novikov O.O., Gureev V.V., Denisyuk T.A., Korokina L.V., Polyanskaya O.S., Ragulina V.A., Pokrovskaya T.G., Danilenko L.M., Belous A.S. Effect of l-arginine, vitamin b6 and folic acid indicators of endothelial dysfunction and microcirculation in the placenta in the simulation l-name-induced nitric oxide deficiency // Bulletin of Experimental Biology and Medicine. 2011. T. 152. № 7. Р. 77-79.5. Korokin M.V., Nosov A.M., Pokrovskiy M.V., Artyushkova E.B., Pokrovskaya T.G., Metel'skaya V.A., Kochkarov V.I., Korokina L.V., Faytel'son A.V., Gudyrev O.S., Pashin E.N., Dudka V.T., Tumanova N.G. Comparative study endotelio- and cardioprotective properties furostanol glycosides from plant cell cultures Dioscorea deltoidea and 17p-estradiol Kuban // Research Medical Gazette. 2006. № 9. Р. 137-140. 6. Kochkarov V.I., Pokrovskiy M.V., Korneev M.M., Pokrovskaya T.G., Gladchenko M.P., Artyushkova E.B., Metel'skaya V.A., Tumanova N.G., Faytel'son A.V., Dudka V.T., Klyavs Yu.P., Zelenkova T.I., Gudyrev O.S.  endotelioprotektivnye effects of resveratrol and its combination with enalapril and losartan in experimental modeling of nitric oxide deficiency Kuban // Research Medical Gazette. 2006. № 9. Р. 150-152.7. Lazarevа G.A., Brovkina I.L., Prokopenko L.G. Essentiale and Riboxinum as inducers of immunomodulatory activity of the stroma of red blood cells in normal and toxic forms of anemia // Experimental and Clinical Pharmacology. 2004. T. 67. № 5. Р. 23-27.8. Saveliev V.S., Yablokov E.G., Petukhov V.A. Lipid distress syndrome in Gia hirur // Bul. Exper. biol. T. 1999. 127, number 6. Р. 604-611.9. Savelyev V.S., Petukhov V.A., An E.S. Endothelial dysfunction in lipid distress syndrome and dismetabolic consequences of peritonitis. // Russian Medical Journal. 2009. T. 17, №14. Р 1-11.10. Pokrovskiy M.V., Artyushkova E.B., Pokrovskaya T.G. Methods of experimental modeling of endothelial dysfunction // Allergology and Immunology. 2008. V. 9. № 3. Р. 32711. Tsepeleva S.A., Pokrovskiy M.V., Pokrovskaya T.G., Korokin M.V., Denisyuk T.A., Kotel'nikova L.V., Lopatin D.V., Titareva L.V., Chernomortseva E.S., Dudina E.N., Konovalova E.A., Losenok P.I., Loktionova I.L., Terekhova E.G., Babko S.A. Cardio and endotelioprotektivnye effects of arginase inhibitor l-norvaline in modeling l-name induced nitric oxide deficiency Kuban // Research Medical Gazette. 2011. № 4. Р. 185-188.12. Broekhuizena Lysette N., Mooija Hans L., Kasteleina John J.P... Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease // Current Opinion in Lipidology 2009.  20: 57–6213. Becker. I. Bernhard F., Daniel Chappell, Dirk Bruegger. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential //CardiovascRes (2010) 87 (2): 300-310.14. Diamant M., Tushuizen M., Abid-Hussein Mohammed. Simvastatin induces endothelial cell anoikis and release of caspase 3-containing microparticles // Int. Soc. Hypertens //.  2006. Vol. 43. Р. 345  367.15. Pokrovskiy M.V., Kochkarov V.I., Pokrovskaya T.G., etc., «Comparative study of potential endothelioprotectors and impaza in modeled nitric oxide deficiency» The Bulletin of experimental biology and medicine, 148 (3): 514-7 (2009).